Ledger.Open graph →
SEC Form D · filed December 15, 2015

CONSTELLATION PHARMACEUTICALS INC

Offering
$55.8M
Sold
$55.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Ariel E. Tseitlin · BOSTON, MAExecJames E. Audia · Cambridge, MAExecAmol Desai · Lafayette, LADirectorGreg Dracon · BOSTON, MAExec · DirectorMatthias E. Jaffe · Cambridge, MAExecWayne S. Kirk · Vancouver, British Columbia, CanadaExecJoseph Kinsella · BOSTON, MADirectorRobert C. Mcguire · PITTSBURGH, PADirectorJayendra E. Das · BOSTON, MAExec · DirectorJeffrey S. Muir · Atlanta, GADirectorJonathan C. Trousdale · Dania Beach, FLDirectorRobert A. Tepper · Cambridge, MADirectorKenneth Towers · Camana Bay, Grand Cayman, Cayman IslandsExecDavid A. Goeddel · Cambridge, MADirectorMark S. Fields · Vancouver, British Columbia, CanadaDirectorAnthony A. Evnin · Cambridge, MADirectorTom A. Maniatis · Cambridge, MADirectorKeith Dionne · Cambridge, MAExec · DirectorDale A. Buckwalter · PITTSBURGH, PAExecMichael R. Cooper · Cambridge, MAExecStephen C. O'Meara · Dania Beach, FLExecAQR Investment Fund GP, LLC · Greenwich, CTExec · DirectorMichael T. Puckett · New Orleans, LADirectorMark A. Goldsmith · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗